Your browser doesn't support javascript.
loading
Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future / 生物工程学报
Chinese Journal of Biotechnology ; (12): 571-592, 2020.
Article in Chinese | WPRIM | ID: wpr-827010
ABSTRACT
The ongoing outbreak of the coronavirus disease 2019 (COVID-19) as named by the World Health Organization has millions of confirmed cases around the world and has claimed hundreds of thousands of lives. The virus was named SARS-CoV-2 in February by International Committee on Taxonomy of Viruses. COVID-19 presents as fever, dry cough, dyspnea, headache and pneumonia. In a small subset of severe cases, the disease quickly progresses to respiratory failure and even death. Since the 21st century, there have been three major outbreaks caused by human coronaviruses, including the severe acute respiratory syndrome (SARS) that broke out in 2003, the Middle East respiratory syndrome (MERS) in 2012, and the recent pandemic of COVID-19. Since 2003, significant progress has been made in the study of SARS-CoV and MERS-CoV concerning their natural origins, pathogenesis, antiviral development and vaccine design. Since SARS-CoV-2 and SARS-CoV are closely related, previous findings on SARS-CoV are highly relevant to a better understanding as well as diagnosis, treatment, prevention and control of SARS-CoV-2. In this review, we highlight recent progresses in the field; compare the biological characteristics of SARS-CoV and SARS-CoV-2; summarize the urgently-needed diagnostic, treatment, prevention and control options; and provide future perspectives for the outcome of the outbreak and research questions to be answered, including some of the difficulties in vaccine development. Hopefully, our comments and suggestions would prove useful for the control of the SARS-CoV-2 epidemic in China and the world.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Antiviral Agents / Pharmacology / Pneumonia, Viral / Therapeutics / Virology / Virulence / Viral Vaccines / Coronavirus Infections / Severe Acute Respiratory Syndrome / Severe acute respiratory syndrome-related coronavirus Type of study: Diagnostic study Limits: Humans Language: Chinese Journal: Chinese Journal of Biotechnology Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Antiviral Agents / Pharmacology / Pneumonia, Viral / Therapeutics / Virology / Virulence / Viral Vaccines / Coronavirus Infections / Severe Acute Respiratory Syndrome / Severe acute respiratory syndrome-related coronavirus Type of study: Diagnostic study Limits: Humans Language: Chinese Journal: Chinese Journal of Biotechnology Year: 2020 Type: Article